Reproducibility Study of OABSS and Its Response to Solifenacin Treatment (RESORT) and Validity in Korean Populations; Part 2: Responsiveness and Validity.
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2013
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms RESORT-2
- Sponsors Astellas Pharma
- 08 Jul 2013 Last checked against ClinicalTrials.gov record.
- 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Mar 2011 New trial record